GINZA NOA CLINIC
Tokyo, Japan International Patient Support
Contact Us

How Soon Might Stem Cell Effects Appear?

Short answer: There is no reliable onset date for stem cell treatments as a group. Blood stem cell transplant recovery takes months, but recovery is not the same as first symptom relief [1]. One approved mesenchymal stromal cell (MSC) treatment assessed response at day 28 for a specific transplant complication [2]. Knee-injection trials assessed pain at six months; that visit does not establish when improvement began or prove cartilage repair [3]. Any useful estimate must name the treatment, diagnosis, and outcome—and allow for no benefit.

What counts as an effect?

A treatment date, a change in symptoms, and evidence of tissue repair answer different questions.

How Soon Might Stem Cell Effects Appear?

Symptom relief

Less pain or easier movement matters to daily life. It does not, by itself, show that injected cells caused the change or that tissue grew back. Other treatment, rehabilitation, and changes in activity must be considered when interpreting improvement.

Recovery after transplant

After a blood stem cell transplant, doctors monitor blood counts and immune recovery. A change in one test does not mean that the entire immune system has recovered [1].

Tissue repair

A repair claim needs evidence of structural change, not just a lower symptom score. The knee review discussed below found that disease progression had not been assessed in any included study [3].

Response at a study visit

A study may assess response on a planned date. A response at that visit does not identify the first day of benefit, guarantee lasting improvement, or mean every participant responded.

Blood transplant recovery takes months

Blood-forming stem cell transplantation has established uses in selected cancers and blood disorders. It restores blood production after intensive treatment; donor immune cells can also attack remaining leukemia cells. It is not interchangeable with a joint injection or other clinic service [1].

NCI describes preparatory treatment lasting about 1 to 2 weeks and the cell infusion itself lasting 1 to 5 hours. Those are procedure times, not onset estimates. Immune recovery can take several months after an autologous transplant, using your own cells, and 1 to 2 years after an allogeneic transplant, using donor cells [1].

For people who travel for a donor transplant, NCI describes going home around 100 days after receiving the cells if there are no complications. This is not a fixed hospital stay or proof of full recovery; close follow-up remains necessary [1].

What day 28 and six months actually mean

In the United States, the FDA approved Ryoncil on December 18, 2024 for steroid-refractory acute graft-versus-host disease in children aged two months and older. This donor bone-marrow-derived MSC product is given intravenously. Its 54-patient single-arm study reported a 70% overall response rate at day 28, including complete and partial responses, without a concurrent control group [2].

That is a response assessment after treatment for a specific complication, not a promise that any MSC injection will work within four weeks. The FDA describes an initial course of eight infusions over four weeks, not one injection followed by a waiting period [2].

For knee osteoarthritis, a 2025 Cochrane review included 25 randomized trials with 1,341 participants across several different comparisons. Only eight trials, with 459 participants, compared stem cell injections with placebo. The review reported pain about 1.2 points better on a 0-to-10 scale at six months versus placebo, with low-certainty evidence. The total of 1,341 is therefore not the sample size for that placebo comparison or necessarily for an individual outcome analysis [3].

The six-month result does not establish an onset date. The review found uncertainty about serious harms, and none of its included studies assessed disease progression. Preparations and doses varied, limiting how confidently the results can be applied to a particular injection [3].

TreatmentWhat the timing describesWhat it does not show
Blood stem cell transplantImmune recovery over several months with own cells, or 1 to 2 years with donor cells [1]A universal date for symptom relief or complete recovery
Ryoncil for its approved pediatric indicationOverall response assessed at day 28 in a 54-patient single-arm study [2]Onset after other MSC products or treatment for other diseases
Knee injections studied in trialsLow-certainty pain results at six months versus placebo [3]When benefit first began or whether cartilage regenerated
A clinic service without matching clinical evidenceNo reliable estimate can be drawn from an advertised waiting period aloneThat waiting longer will produce benefit

Why one timeline cannot fit every treatment

Stem cells can self-renew and develop into specialized cells, but their biological properties do not establish the effectiveness of a particular treatment [4]. Cell source, processing, dose, delivery route, diagnosis, and other care need to match the evidence behind a timing claim. A vein infusion and a knee injection are not equivalent.

The FDA warns about unapproved regenerative products marketed for orthopedic, neurological, cardiovascular, and other conditions. Such marketing does not establish an effective treatment or an onset schedule [5]. Animal experiments and trial registration also cannot establish when a person will benefit: registration documents a study, not a successful result.

How to judge your own progress

Before treatment, agree on the outcome, baseline measurement, follow-up dates, and what would count as no meaningful change. Ask whether each visit is timed from the first dose, the last dose, or another milestone.

For example, if your goal is easier stair climbing, record the same activity under similar conditions before treatment and at the visits agreed with your clinician. Note pain, assistance needed, medicines, and rehabilitation changes. This is a suggested observation method, not a patient case or a validated test of cell activity. A personal record can help a consultation; it cannot prove the cells caused an improvement.

If you feel no better at an agreed review, ask what the results mean and whether the plan should change. Do not assume that the cells simply need more time or that another dose will help.

A clinician should interpret new or worsening symptoms rather than asking you to wait for a promised benefit. Do not stop established treatment or postpone appropriate care to follow an unverified onset claim.

Safety cannot wait for an effect

After blood transplantation, both preparatory treatment and the transplant can cause serious complications. Donor transplants can cause graft-versus-host disease; long-term problems can include organ damage. Feeling better is not a reason to stop follow-up [1].

For unapproved regenerative products, the FDA reports serious infections, blindness, and tumor formation. Using your own cells does not eliminate processing, contamination, or immune risks [5]. Approved products also have risks: the Ryoncil approval notice lists infections and fever among common adverse reactions [2].

Follow your team’s emergency instructions. Seek urgent medical help for breathing difficulty, chest pain, sudden vision changes, or other severe symptoms. Report fever, increasing redness, or worsening pain promptly; do not wait for a routine review.

What Japan registration tells you

Japan distinguishes medical care and research under the Act on the Safety of Regenerative Medicine from commercial product authorization under the Pharmaceuticals and Medical Devices Act. A clinic’s provision plan is not the same as approval of a named product for a specific indication, and neither a registration claim nor a regulatory product count supplies an onset date [6].

Ask the clinic to identify the exact product or preparation, its regulatory pathway, and the human evidence that matches your condition. U.S. approval of a product does not establish approval of a different Japanese clinic service.

What to ask before accepting a timeline

  • Which diagnosis, disease stage, cells, dose, and delivery route does the estimate cover?
  • Is the date about symptoms, a laboratory result, recovery, or structural repair?
  • What human study supports it, how many people were studied, and what was the comparison?
  • When will progress be checked, and what happens if there is no meaningful benefit?
  • Which risks need urgent attention, and who is available between visits?

Have questions about a proposed timeline?

Ask which preparation, outcome, follow-up schedule, and safety plan apply to your enquiry. An enquiry does not establish eligibility or expected benefit.

Send an enquiry

Bottom line

There is no general answer of days, weeks, or months for stem cell effects. Transplant recovery, a day-28 response assessment, and a six-month pain assessment describe different outcomes—not a shared onset schedule [1] [2] [3]. Ask for a treatment-specific estimate, a measurable review plan, and an honest explanation of the possibility of no benefit.

This article provides general information, not personal medical advice. Discuss timing and treatment choices with a licensed physician who can review your diagnosis, records, and established alternatives.